Indo-MIM IPO vs Sai Parenteral's IPO

Comparison between Indo-MIM IPO and Sai Parenteral's IPO.

IPO Details

Indo-MIM IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sai Parenteral's IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Indo-MIM IPO is up to ₹0.00 Cr whereas the issue size of the Sai Parenteral's IPO is up to ₹408.79 Cr. The final issue price of Indo-MIM IPO is and of Sai Parenteral's IPO is ₹392.00 per share.

 Indo-MIM IPOSai Parenteral's IPO
Face Value₹1 per share₹5 per share
Issue Price (Lower)₹372.00 per share
Issue Price (Upper)₹392.00 per share
Issue Price (Final)₹392.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size38 shares
Fresh Issue Size0 shares72,70,408 shares
Fresh Issue Size (Amount)up to ₹100.00 Crup to ₹285.00 Cr
OFS Issue Size12,96,74,393 shares31,57,880 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹123.79 Cr
Issue Size Total0 shares1,04,28,288 shares
Issue Size Total (Amount)up to ₹0.00 Crup to ₹408.79 Cr

IPO Timetable

Indo-MIM IPO opens on , while Sai Parenteral's IPO opens on Mar 24, 2026. The closing date of Indo-MIM IPO and Sai Parenteral's IPO is , and Mar 27, 2026, respectively.

Financials & KPIs

Indo-MIM IPO P/E ratio is , as compared to Sai Parenteral's IPO P/E ratio of 72.19.

 Indo-MIM IPOSai Parenteral's IPO
Financials

Company Financials (Restated Consolidated)

Indo-MIM Ltd.'s revenue increased by 16% and profit after tax (PAT) rose by 49% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets4,140.843,757.513,380.45
Total Income3,373.972,900.382,760.65
Profit After Tax423.73283.73462.69
EBITDA932.60743.46782.53
NET Worth2,199.432,050.511,999.56
Reserves and Surplus2,030.811,889.041,871.75
Total Borrowing1,247.201,085.01807.91
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets376.24272.39268.10133.96
Total Income89.43163.74155.1897.03
Profit After Tax7.7614.438.424.38
EBITDA16.2439.4431.7017.64
NET Worth209.3795.7876.4031.49
Reserves and Surplus188.8480.3661.3024.34
Total Borrowing76.0793.95118.7968.55
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)93.3461.23
Promoter Shareholding (Post-Issue)51.2
P/E Ratio72.19
Market Cap₹1731.83 Cr.
ROE19.94%16.82%
ROCE23.51%28.92%
Debt/Equity0.57
EPS₹5.43
RoNW19.94%15.09%

Shares Offered

In the Indo-MIM IPO Retail Individual Investors (RII) are offered 0 shares while in Sai Parenteral's IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Indo-MIM IPO and 20,85,658 shares in Sai Parenteral's IPO.

 Indo-MIM IPOSai Parenteral's IPO
Anchor Investor Reservation0 shares31,28,485 shares
Market Maker Reservation0 shares0 shares
QIB0 shares20,85,658 shares
NII0 shares15,64,244 shares
RII0 shares36,49,901 shares
Employee0 shares0 shares
Others
Total0 shares1,04,28,288 shares

Bids Received (Subscription)

Indo-MIM IPO subscribed in total, whereas Sai Parenteral's IPO subscribed 1.08x.

Compare with others

Compare: